.png)

When a Cayman Islands holding company, BVI entity, or any foreign parent sits above your U.S. operating company, U.S. institutional Series B investors face structural problems that go far beyond standard paperwork. These cross-border arrangements can trigger intensive national security reviews under the Committee on Foreign Investment in the United States (CFIUS), expose tax-exempt limited partners to unwanted unrelated business taxable income (UBTI), create complex sanctions and beneficial-ownership diligence friction, and directly conflict with fund mandates prohibiting foreign entity investments. Because a lead investor discovering an undisclosed offshore layer mid-diligence will typically withdraw rather than wait to resolve it, founders must proactively treat cap table cleanups as a vital element of their pre-marketing preparation. Executing a security-by-security reorganization 6 to 12 months before launching a raise ensures a clean, investable Delaware structure that satisfies institutional standards and maintains critical fundraising momentum.
Key takeaways:
This article is part of the series on cap table issues that kill a Series B before the lead investor reads your deck.
There are four distinct reasons a U.S. institutional fund may be legally or structurally unable to invest when a foreign entity sits in the ownership chain. Each one operates independently. A company does not need to trigger all four to lose the lead.
Founders build offshore holding structures for legitimate reasons: early foreign investor accommodation, tax planning, or international operations. The problem is not the original intent. The problem is what the structure looks like to a U.S. institutional fund at Series B.
Understanding which structure you have is the first step. Each one requires a different reorganization path, and the documentation requirements are not identical. Founders who understand how capital structures affect investor expectations before approaching a Series B are far better positioned to address these questions before they become deal-killers.
A reorganization is not a single filing. It is a security-by-security, entity-by-entity process that touches every layer of the ownership chain. Here is what it typically involves.
Founders who are also working through debt and equity structure decisions as part of Series B preparation should complete the entity reorganization first. A clean cap table in a clean entity is the prerequisite for every other financing decision.
The offshore entity problem compounds quickly when other structural issues exist in the same cap table. How stacked SAFEs and convertible notes silently destroy your Series B cap table explains how instrument-level dilution problems layer on top of entity-level problems to make a round structurally unfundable. And how investors use pre-money option pool mechanics to quietly dilute founders before the round closes is the third structural lever that gets pulled at Series B, often before the first partner meeting.
The offshore structure does not just slow down diligence. It creates specific risk zones that can end the process at any point after the first conversation.
"CFIUS assesses the ultimate foreign beneficial owner and control, regardless of intermediary jurisdictions." — U.S. Department of the Treasury, CFIUS Laws and Guidance
The part most coverage misses: fund counsel's concern is not always about the legal risk to the fund. It is often about the signal the structure sends about how the company was built and managed.
The hard truth: a reorganization that takes three months before the raise takes six months during it, and it often takes the lead investor with it.
When a restructuring surfaces mid-process, it does not just add time. It changes the nature of the process entirely.
The right approach is to treat the reorganization as part of Series B preparation, not as a response to investor feedback. The process for raising institutional capital in 2026 rewards founders who arrive at market with a clean, investable structure already in place.
Start the offshore restructuring at least 12 months before launching a Series B process. Here is the pre-raise checklist.
Understanding how Series A valuations are calculated and what institutional investors look for is relevant context here. Investors at Series B apply the same structural scrutiny, and a clean entity structure is a prerequisite for that conversation.
In most cases, no. A Cayman holding company sitting above a U.S. operating entity creates CFIUS exposure, potential fund mandate conflicts, and beneficial-ownership diligence requirements that U.S. institutional funds cannot resolve mid-process. Some funds may engage if the Cayman layer holds no foreign-government-linked ownership and the business is outside TID sectors, but this is the exception and requires advance legal analysis, not a discovery conversation during diligence.
CFIUS is the U.S. government committee that reviews foreign investment in U.S. businesses for national security implications. Under FIRRMA, it covers foreign control of any U.S. business and certain non-controlling investments in TID sectors. For startups, CFIUS review means a formal notice process with a 30-day initial review period and a potential 45-day investigation period. CFIUS can require mitigation agreements, impose conditions, or block transactions. Investors cannot close a financing round with an unresolved CFIUS review.
A straightforward reorganization, collapsing a single Cayman or BVI layer into a clean U.S. entity, typically takes 3-6 months when started with adequate runway. Complex structures involving multiple offshore entities, foreign government-linked investors, or nominee arrangements can take 9-12 months or longer. This is why the 12-month pre-raise timeline matters. Starting after investor conversations begin is almost always too late.
Foreign investor equity is exchanged into shares of the U.S. entity on negotiated terms. The exchange ratio, share class, and investor rights must be documented in new subscription agreements and reflected in the updated cap table and stock ledger. Foreign investors must consent to the exchange. If any foreign investor refuses, the restructuring cannot be completed and the Series B process cannot proceed on a clean basis.
In some cases, fund managers use parallel fund structures or offshore feeder vehicles to block UBTI at the fund level rather than requiring a company-level restructuring. However, this approach depends entirely on the fund's architecture and its LP composition. It is not a solution the company controls. If the lead fund does not have an offshore feeder or a UBTI blocker structure in place, the company's offshore layer remains a problem regardless of what the company would prefer.
A nominee arrangement is a structure in which a person or entity holds equity or governance rights on behalf of another party whose identity is not disclosed in the corporate records. Nominee arrangements are common in certain offshore jurisdictions. They surface in diligence because institutional investors require complete beneficial ownership transparency. A nominee arrangement that is not disclosed before diligence begins is treated as a material misrepresentation, not a technical issue.
It depends on the nature of the foreign parent's control and the sector the company operates in. A foreign parent with majority control of a U.S. business in a TID sector faces the highest CFIUS exposure and is the hardest to resolve. A foreign parent with a minority, non-controlling interest in a U.S. business outside TID sectors may be manageable with proper documentation and CFIUS counsel review. In all cases, the foreign parent's involvement must be fully disclosed before investor outreach begins, and the company must obtain legal analysis of the CFIUS question before approaching a lead.
*Most founders don't lose the raise because of the pitch. They lose it because the structure was wrong before the first investor call. IRC Partners advises founders raising $5M to $250M of institutional capital. 7 strategic partners per quarter. Start here to schedule a call with our team.
You get one shot to raise the right way. If this raise is worth doing, it’s worth doing with precision, leverage, and control.
This isn’t a practice run. Serious capital. Serious strategy. Let’s raise it right.
We onboard a maximum of 7
new strategic partners each quarter, by application only, to maximize your chances of securing the capital you need.